July 2026 in “Journal of Dermatological Treatment”
This study observed that excimerlaser therapy led to subjective improvements in hair appearance for 60% of scarring alopecia patients and reduced symptoms like scalp pain, burning, and pruritus, indicating potential as an adjunctive treatment for inflammatory control and disease stabilization.
This study evaluated the 308-nmexcimerlaser as an adjuvant treatment for frontal fibrosing alopecia and found it may stabilize hairline recession and improve erythema and perifollicular hyperkeratosis, with transient erythema as the only reported adverse effect.
August 2021 in “Journal of advances in medicine and medical research”
In this study, both excimer light and low level light therapy were found to be safe and effective for treating alopecia areata, with excimer light showing better and more sustained improvement.
This review suggests that 308 nmexcimer therapy may offer a well-tolerated non-pharmacologic option for alopecia areata, with more limited evidence for its effectiveness in lichen planopilaris and frontal fibrosing alopecia.